HTL Biotechnology launches HTL8
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
This milestone reflects our shared commitment to Corporate Social Responsibility (CSR) throughout 2023.
It showcases the key initiatives and achievements that drive our company towards greater sustainability and responsibility.
This report is the result of a true team effort, and we extend our warmest thanks to everyone who contributed to making it.
🔗 Discover the 2023 CSR Report here
Beyond together, sustainably.
A new production unit dedicated to pharmaceutical-grade Polynucleotides (DNA) at our Javené site.
HTL Biotechnology hosted a scientific summit in Chengdu, China, dedicated to PDRN/PN, bringing together more than 130 experts and professionals to discuss the latest scientific advances, regulatory developments and emerging applications.
Driven by the collective commitment of our teams, this report confirms the maturity of an internationally recognized approach, which was recognized this year with the EcoVadis Platinum medal, placing HTL Biotechnology among the top 1% of the world’s most committed companies.